Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ mice

被引:19
作者
Irie, M
Homma, S
Komita, H
Zeniya, M
Kufe, D
Ohno, T
Toda, G
机构
[1] Jikei Univ, Sch Med, Inst DNA Med, Dept Oncol,Minato Ku, Tokyo 1058461, Japan
[2] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
dendritic cell; hepatocellular carcinoma; cancer vaccine; macrophage; IFN-gamma; CD4(+) T cell;
D O I
10.1002/ijc.20247
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We attempted to prevent spontaneous development of liver tumors by s.c. inoculation with DCs loaded with syngeneic HCC cells in C3H/HeNCrj mice. A new cell line, MIH-2, was established from an HCC that had developed spontaneously in a C3H/HeNCrj mouse. Bone marrow-derived DCs were loaded with irradiated MIH-2 cells by treatment with PEG. Fluorescence microscopy and flow-cytometric analysis showed that about 45% of PEG-treated DCs and MIH-2 cells (DC/MIH-2) were DCs loaded with MIH-2 cells. Thirteen-month-old mice received inoculations of DC/MIH-2 (9 X 10(5)/ mouse) 4 times at 6-day intervals and were killed at 16 months of age to assess liver tumors. The incidence of liver tumors in these mice was significantly lower than that in mice not receiving inoculations (p < 0.05) but similar to that in 13-month-old mice (the age at which inoculation started), indicating that inoculation inhibited the development of new tumors. Splenocytes from inoculated mice, but not those from uninoculated mice, showed cytotoxic activity against MIH-2 cells. Cytotoxic activity was not elicited by CD4(+) T cells, CD8(+) T cells, or DX5(+) cells isolated from splenocytes but was elicited by adherent cells, identified as CDIIb(+) macrophages. CD4(+) T cells, but not CD8(+) T cells, from inoculated mice produced IFN-gamma by incubation with DC/MIH-2. Cytotoxicity by splenocytes was attenuated by anti-IFN-gamma antibody. Immunization with DCs loaded with syngeneic HCC cells induces CD4(+) T cells that produce IFN-gamma by response to antigen of HCC, which would lead to macrophage activation to kill liver tumor cells at an early stage. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:238 / 245
页数:8
相关论文
共 51 条
[31]  
Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6
[32]   BONE-MARROW-DERIVED DENDRITIC CELLS PULSED WITH SYNTHETIC TUMOR PEPTIDES ELICIT PROTECTIVE AND THERAPEUTIC ANTITUMOR IMMUNITY [J].
MAYORDOMO, JI ;
ZORINA, T ;
STORKUS, WJ ;
ZITVOGEL, L ;
CELLUZZI, C ;
FALO, LD ;
MELIEF, CJ ;
ILDSTAD, ST ;
KAST, WM ;
DELEO, AB ;
LOTZE, MT .
NATURE MEDICINE, 1995, 1 (12) :1297-1302
[33]   Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma [J].
Muto, Y ;
Moriwaki, H ;
Ninomiya, M ;
Adachi, S ;
Saito, A ;
Takasaki, KT ;
Tanaka, T ;
Tsurumi, K ;
Okuno, M ;
Tomita, E ;
Nakamura, T ;
Kojima, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (24) :1561-1567
[34]   RANDOMIZED TRIAL OF EFFECTS OF INTERFERON-ALPHA ON INCIDENCE OF HEPATOCELLULAR-CARCINOMA IN CHRONIC ACTIVE HEPATITIS-C WITH CIRRHOSIS [J].
NISHIGUCHI, S ;
KUROKI, T ;
NAKATANI, S ;
MORIMOTO, H ;
TAKEDA, T ;
NAKAJIMA, S ;
SHIOMI, S ;
SEKI, S ;
KOBAYASHI, K ;
OTANI, S .
LANCET, 1995, 346 (8982) :1051-1055
[35]   Local ablation therapy for hepatocellular carcinoma [J].
Okada, S .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :323-328
[36]  
Owen MR, 1998, IMA J MATH APPL MED, V15, P165
[37]   Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo [J].
Paglia, P ;
Chiodoni, C ;
Rodolfo, M ;
Colombo, MP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :317-322
[38]   Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma [J].
Poon, RTP ;
Fan, ST ;
Wong, J .
ANNALS OF SURGERY, 2000, 232 (01) :10-24
[39]   Dendritic cells and immunotherapy for malignant disease [J].
Reid, CDL .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) :874-887
[40]   Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes [J].
Romero, P ;
Dunbar, PR ;
Valmori, D ;
Pittet, M ;
Ogg, GS ;
Rimoldi, D ;
Chen, JL ;
Liénard, D ;
Cerottini, JC ;
Cerundolo, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1641-1650